The interplay between lipoprotein phenotypes, adiponectin, and alcohol consumption

References

• Hannuksela ML, Rämet ME, Nissinen AET, Liisanantti MK, Savolainen MJ. Effects of ethanol on lipids and atherosclerosis. Pathophysiology. 2004;10:93–103.
   PubMedGoogle Scholar
• Matsuura F, Oku H, Koseki M, Sandoval JC, Yuasa-Kawase M, Tsubakio-Yamamoto K, . Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem Biophys Res Commun. 2007;358:1091–5.
   PubMed Web of Science ®Google Scholar
• Magge SN, Stettler N, Koren D, Levitt Katz LE, Gallagher PR, Mohler ER 3rd, . Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. J Clin Endocrinol Metab. 2011;96:1549–54.
   PubMed Web of Science ®Google Scholar
• Lin Y, Mousa S, Elshourbagy N, Mousa S. Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy. Vasc Health Risk Manag. 2010;6:73–85.
   PubMedGoogle Scholar
• Rana JS, Arsenault BJ, Després J, Côté M, Talmud PJ, Ninio E, . Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J. 2011;32:336–44.
   PubMed Web of Science ®Google Scholar
• Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab. 2008;93:3357–64.
   PubMed Web of Science ®Google Scholar
• Karakas M, Zierer A, Herder C, Baumert J, Meisinger C, Koenig W, . Leptin, adiponectin, their ratio and risk of coronary heart disease: results from the MONICA/KORA Augsburg Study 1984–2002. Atherosclerosis. 2010;209: 220–5.
   PubMed Web of Science ®Google Scholar
• Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, . Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006; 114:623–9.
   PubMed Web of Science ®Google Scholar
• Beulens JWJ, van Loon LJC, Kok FJ, Pelsers M, Bobbert T, Spranger J, . The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia. 2007;50: 1388–92.
   PubMed Web of Science ®Google Scholar
• Buechler C, Schäffler A, Johann M, Neumeier M, Köhl P, Weiss T, . Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal. J Gastroenterol Hepatol. 2009;24:558–63.
   PubMed Web of Science ®Google Scholar
• Kumpula LS, Mäkelä SM, Mäkinen V, Karjalainen A, Liinamaa JM, Kaski K, . Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps. J Lipid Res. 2010;51:431–9.
   PubMed Web of Science ®Google Scholar
• Kohonen T. Self-organizing maps. Berlin: Springer; 2001.
   Google Scholar
• Hyvönen MT, Hiltunen Y, El-Deredy W, Ojala T, Vaara J, Kovanen PT, . Application of self-organizing maps in conformational analysis of lipids. J Am Chem Soc. 2001;123: 810–6.
   PubMed Web of Science ®Google Scholar
• Hannuksela ML, Liisanantti MK, Nissinen AET, Savolainen MJ. Biochemical markers of alcoholism. Clin Chem Lab Med. 2007;45:953–61.
   PubMed Web of Science ®Google Scholar
• Liinamaa MJ, Kervinen K, Hannuksela ML, Kesäniemi YA, Savolainen MJ. Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers. Alcohol Clin Exp Res. 1997;21:606–12.
   PubMed Web of Science ®Google Scholar
• Mäkelä SM, Jauhiainen M, Ala-Korpela M, Metso J, Lehto TM, Savolainen MJ, . HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles. Alcohol Clin Exp Res. 2008;32:991–1000.
   PubMed Web of Science ®Google Scholar
• Niemi J, Mäkinen V, Heikkonen J, Tenkanen L, Hiltunen Y, Hannuksela ML, . Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs-apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med. 2009;41:451–61.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HBJ, Cleeman JI, Smith SCJ, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13–18.
   PubMed Web of Science ®Google Scholar
• Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem. 1986;32:283–6.
   PubMed Web of Science ®Google Scholar
• Hannuksela M, Marcel YL, Kesäniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res. 1992;33:737–44.
   PubMed Web of Science ®Google Scholar
• Kumpula LS, Kumpula JM, Taskinen M, Jauhiainen M, Kaski K, Ala-Korpela M. Reconsideration of hydrophobic lipid distributions in lipoprotein particles. Chem Phys Lipids. 2008;155:57–62.
   PubMed Web of Science ®Google Scholar
• Mäkinen V, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, . Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes. 2008;57:2480–7.
   PubMed Web of Science ®Google Scholar
• Liinamaa MJ, Hannuksela ML, Kesäniemi YA, Savolainen MJ. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol. 1997;17:2940–7.
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Yoshida H, Okamoto M, Matsuo Y, Suzuki K, Tatara K. Association of alcohol consumption with white blood cell count: a study of Japanese male office workers. J Intern Med. 2003;253:367–74.
   PubMed Web of Science ®Google Scholar
• Hillemacher T, Weinland C, Heberlein A, Gröschl M, Schanze A, Frieling H, . Increased levels of adiponectin and resistin in alcohol dependence -possible link to craving. Drug Alcohol Depend. 2009;99:333–7.
   PubMed Web of Science ®Google Scholar
• Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, . Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68:975–81.
   PubMed Web of Science ®Google Scholar
• Das S, Shahmanesh M, Stolinski M, Shojaee-Moradie F, Jefferson W, Jackson NC, . In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100. Diabetologia. 2006;49:538–42.
   PubMed Web of Science ®Google Scholar
• Qiu X, Mistry A, Ammirati MJ, Chrunyk BA, Clark RW, Cong Y, . Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat Struct Mol Biol. 2007;14:106–13.
   PubMed Web of Science ®Google Scholar
• Matsuura F, Wang N, Chen W, Jiang X, Tall AR. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest. 2006;116:1435–42.
   PubMed Web of Science ®Google Scholar
• Castle CK, Kuiper SL, Blake WL, Paigen B, Marotti KR, Melchior GW. Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein. Am J Physiol. 1998;274:E1091–8.
   PubMedGoogle Scholar
• Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, . Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol. 2005;25: 2185–91.
   PubMed Web of Science ®Google Scholar
• de Souza JA, Vindis C, Hansel B, Nègre-Salvayre A, Therond P, Serrano CV, . Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis. 2008; 197:84–94.
   PubMed Web of Science ®Google Scholar
• Skeggs JW, Morton RE. LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J Lipid Res. 2002;43:1264–74.
   PubMed Web of Science ®Google Scholar
• Jarvis CM, Hayman LL, Braun LT, Schwertz DW, Ferrans CE, Piano MR. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women. J Cardiovasc Nurs. 2007;22:429–35.
   PubMed Web of Science ®Google Scholar
• Baik I, Shin C. Prospective study of alcohol consum- ption and metabolic syndrome. Am J Clin Nutr. 2008;87: 1455–63.
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, Dunn M, Liu C, Liu C, Selzer RH, . Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation. 1997;95:2022–6.
   PubMed Web of Science ®Google Scholar